PRINCETON, N.J., June 29, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced information regarding a key supply chain insight for OC-01 (varenicline) nasal spray ...

SAN FRANCISCO (MarketWatch) -- Pfizer Inc. said Wednesday that the Food and Drug Administration has granted a 6-month priority review for the new drug application for its smoking cessation ...

Varenicline tartrate (Chantix/Champix; Pfizer Inc; New York, New York), a high-affinity α 4 β 2 nicotinic acetylcholine receptor partial agonist, is hypothesized to reduce craving and withdrawal ...

Carson-Chahhoud, K.V., et al. (2020) Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial.

King and colleagues sought to ascertain whether treatment combining varenicline tartrate and a nicotine patch increased abstention from cigarette smoking among smokers who drink heavily.